Get startedLog in
    Picture of Intercept Pharmaceuticals logo

    ICPT — Intercept Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapHigh Flyer
    All News

    Brief: Intercept Pharmaceuticals Reports First Quarter 2023 Financial Results And Provides Update On Commercial Launch Strategy For Nash

    Picture of Intercept Pharmaceuticals logoIntercept Pharmaceuticals
    27/04/2023 12:12
    April 27 (Reuters) - Intercept Pharmaceuticals Inc
 ICPT.O :
    * INTERCEPT PHARMACEUTICALS REPORTS FIRST QUARTER 2023
FINANCIAL
RESULTS AND PROVIDES UPDATE ON COMMERCIAL LAUNCH STRATEGY FOR
NASH
    * INTERCEPT PHARMACEUTICALS INC QTRLY LOSS PER SHARE $0.77
    * INTERCEPT PHARMACEUTICALS - ACTIVELY PROGRESSING LAUNCH
READINESS ACTIVITIES FOR OCA FOR TREATMENT OF PATIENTS WITH
PRE-CIRRHOTIC FIBROSIS DUE TO NASH

Source text for Eikon:  ID:nGNX81hB6j 
Further company coverage:  ICPT.O 

 (Reporting by Siddarth S)
 ((Siddarth.s@thomsonreuters.com;))

    Recent news on Intercept Pharmaceuticals

    See all news